A Phase 2b study of M512101 in acne vulgaris for 12weeks
Phase 2
- Conditions
- Acne vulgaris
- Registration Number
- JPRN-jRCT2080221363
- Lead Sponsor
- Maruho Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients diagnosed with acne vulgaris
2. Outpatient
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percent reduction in inflammatory lesion counts.
- Secondary Outcome Measures
Name Time Method